Toplak, Hermann
Bilitou, Aikaterini http://orcid.org/0000-0002-0125-9562
Alber, Hannes
Auer, Johann
Clodi, Martin
Ebenbichler, Christoph
Fließer-Görzer, Evelyn
Gelsinger, Carmen
Hanusch, Ursula
Ludvik, Bernhard
Maca, Thomas
Schober, Andreas
Sock, Reinhard
Speidl, Walter S.
Stulnig, Thomas M.
Weitgasser, Raimund
Zirlik, Andreas
Koch, Marina
Wienerroither, Sebastian
Wolowacz, Sorrel E.
Diamand, Françoise
Catapano, Alberico L.
Funding for this research was provided by:
Daiichi Sankyo Europe
Article History
Received: 11 January 2023
Accepted: 7 May 2023
First Online: 8 June 2023
Declarations
:
: C. Gelsinger, T. Maca, R. Sock declare that they have no competing interests. S. Wolowacz is an employee of RTI Health Solutions. RTI Health Solutions received funding from Daiichi Sankyo Europe GmbH for the preparation of this manuscript. A. Bilitou, M. Koch, S. Wienerroither, and F. Diamand are employees of Daiichi Sankyo. Daiichi Sankyo Europe GmbH is the market authorisation holder in Europe, Switzerland, and the United Kingdom for bempedoic acid and bempedoic acid fixed-dose combination with ezetimibe. All co-authors received study fees from Daiichi Sankyo. H. Toplak has received honoraria for lecturing and consulting as well as research support from Daiichi Sankyo. H. Alber has received study fees from Daiichi Sankyo, and lecture and consulting fees from Daiichi Sankyo, Novartis, Amgen, and Sanofi-Aventis. J. Auer has received consulting work and lecture fees from Novartis, Amgen, Sanofi, and Daiichi Sankyo. M. Clodi has received lecture and consultant fees from Astra Zeneca, Boerhinger Ingelheim, Novo Nordisk, Novartis, Sanofi, Amgen, and Daiichi Sankyo. C. Ebenbichler has received grants and personal fees from Abbott, Amgen, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Novartis, NovoNordisk, Sanofi, and Sobi. E. Fließer-Görzer has received presentation, study, and/or congress support from Novo Nordisk, AstraZeneca, Bristol-Myers Squibb, Bayer, Novartis, Eli Lilly, Allergan, Daiichi Sankyo, Amgen, Merck Sharpe & Dohme, Boehringer Ingelheim, and Sanofi Aventis. U. Hanusch has acted as investigator in clinical trials conducted by Bayer, Lilly, Amgen, Vertanical, and Novo Nordisk. B. Ludvik has received honoraria for lectures, advisory boards, and research support from Amgen, Sanofi, Novartis, and Daiichi Sankyo. A. Schober has received speaker fees and institutional research support from Daiichi-Sankyo. W. Speidl has received support for lectures, advisory board participation, clinical trials, and/or other research from Amgen, Daiichi Sankyo, Novartis, and Sanofi. T. Stulnig has received honoraria for lectures and/or consultation as well as travel support from Amgen, Daiichi-Sankyo, Novartis, Sanofi, Sobi; research support from Daiichi-Sankyo and Sanofi. R. Weitgasser has received research grants, speaker fees, and consultant advisory board fees (2017–2022) from the following: Abbott Diabetes Care, Amgen, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, Medtrust, Merck Sharp & Dohme, Novo Nordisk, Roche Diabetes Care, Sanofi, and Spar. A. Zirlik has received consultant fees from Bayer Health Care, Boehringer Ingelheim, Rigel, Cardiorentis, Medscape Stealth Peptides, Sanofi Aventis, Medtronic, Norvatis and honoraria for lectures from Bayer Health Care, Astra Zeneca, Medtronic, ResMed, Boehringer Ingelheim, Rigel, Sanofi Aventis, Pfizer, Janssen-Cilag, Novartis, Bristol Myers Squibb, Thoratec, Abiomed, Daiichi Sankyo, Abbott and Cardiac Dimensions. A.L. Catapano has received honoraria, lecture fees, or research grants from the following: Amarin, Sigma-Tau, Menarini, Kowa, Recordati, Eli Lilly, AstraZeneca, Mediolanum, Pfizer, Merck, Sanofi, Aegerion, Amgen, Genzyme, Bayer, Sanofi, Regeneron, Daiichi Sankyo, and The Corpus. The work of A.L. Catapano is supported in part by the Italian Ministry of Health—Ricerca Corrente.
: All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants for being included in the study.